Karassa FB - Search Results

1

Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.

Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM. Vlachoyiannopoulos PG, et al. Among authors: karassa fb. Lupus. 1993 Oct;2(5):303-12. doi: 10.1177/096120339300200505. Lupus. 1993. PMID: 8305923

2

The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.

Karassa FB, Trikalinos TA, Ioannidis JP. Karassa FB, et al. Biomed Pharmacother. 2004 Jun;58(5):286-91. doi: 10.1016/j.biopha.2004.04.004. Biomed Pharmacother. 2004. PMID: 15194164

3

Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.

Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, Michel M, Piette JC, Salmon JE, Song YW, Tsuchiya N, Yoo DH, Ioannidis JP. Karassa FB, et al. Arthritis Rheum. 2003 Jul;48(7):1930-8. doi: 10.1002/art.11059. Arthritis Rheum. 2003. PMID: 12847687 Free article.

4

Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.

Karassa FB, Tatsioni A, Ioannidis JP. Karassa FB, et al. J Rheumatol. 2003 May;30(5):979-84. J Rheumatol. 2003. PMID: 12734892

5

Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.

Karassa FB, Trikalinos TA, Ioannidis JP; FcgammaRIIa-SLE Meta-Analysis Investigators. Karassa FB, et al. Arthritis Rheum. 2002 Jun;46(6):1563-71. doi: 10.1002/art.10306. Arthritis Rheum. 2002. PMID: 12115187 Free article.

6

The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis.

Karassa FB, Trikalinos TA, Ioannidis JP; Fc gamma RIIIA-SLE meta-analysis investigators. Karassa FB, et al. Kidney Int. 2003 Apr;63(4):1475-82. doi: 10.1046/j.1523-1755.2003.00873.x. Kidney Int. 2003. PMID: 12631364 Free article.

7

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.

Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IE, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JP. Karassa FB, et al. Arthritis Rheum. 2006 Jan;54(1):312-24. doi: 10.1002/art.21539. Arthritis Rheum. 2006. PMID: 16385548 Free article.

8

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM. Karassa FB, et al. Am J Med. 2000 Dec 1;109(8):628-34. doi: 10.1016/s0002-9343(00)00603-3. Am J Med. 2000. PMID: 11099682

9

Risk factors for central nervous system involvement in systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Karassa FB, et al. QJM. 2000 Mar;93(3):169-74. doi: 10.1093/qjmed/93.3.169. QJM. 2000. PMID: 10751236

10

Late renal transplant arterial thrombosis in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Karassa FB, Avdikou K, Pappas P, Nakopoulou L, Kostakis A, Boletis JN. Karassa FB, et al. Nephrol Dial Transplant. 1999 Feb;14(2):472-4. doi: 10.1093/ndt/14.2.472. Nephrol Dial Transplant. 1999. PMID: 10069218 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results